Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease.

MLA

Djavid, Amir Reza, et al. “Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease.” Annals of the American Thoracic Society, vol. 18, no. 11, Nov. 2021, pp. 1924–27. EBSCOhost, https://doi.org/10.1513/AnnalsATS.202102-220RL.

APA

Djavid, A. R., Thompson, A. E., Irace, A. L., Gusman, E., Altman, K., DiMango, E. A., & Keating, C. L. (2021). Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease. Annals of the American Thoracic Society, 18(11), 1924–1927. https://doi.org/10.1513/AnnalsATS.202102-220RL

Chicago

Djavid, Amir Reza, Alison E Thompson, Alexandria L Irace, Elen Gusman, Kimberly Altman, Emily A DiMango, and Claire L Keating. 2021. “Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease.” Annals of the American Thoracic Society 18 (11): 1924–27. doi:10.1513/AnnalsATS.202102-220RL.